Proctitis is inflammation of the lining of the rectum, and it shows up most often for one of two reasons: a sexually transmitted infection or inflammatory bowel disease. Symptoms typically include rectal bleeding, mucus discharge, a persistent feeling of needing to go (called tenesmus), and sometimes lower abdominal pain.1PubMed Central. Separating Infectious Proctitis from Inflammatory Bowel Disease-A Common Clinical Conundrum But the list of possible causes is longer than most people expect, and the treatment that works depends entirely on which cause is driving the inflammation.
What Causes Proctitis
The broad categories include infection, inflammatory bowel disease, radiation exposure, reduced blood flow, medication side effects, and immune reactions to food proteins in infants.2Journal of Clinical Gastroenterology. Diagnosis and Treatment of Ulcerative Proctitis In practice, sexually transmitted infections and ulcerative proctitis (the form of inflammatory bowel disease confined to the rectum) account for the vast majority of cases seen in clinics. Radiation proctitis, ischemic proctitis, and diversion proctitis are real but much less common, and they tend to arise in very specific clinical circumstances.
Infectious Proctitis and Its Rising Incidence
The rate of infectious proctitis has been climbing, particularly among men who have sex with men, people living with HIV, and those engaging in receptive anal intercourse. The organisms most often responsible are gonorrhea, chlamydia (including the aggressive lymphogranuloma venereum strains), syphilis, and herpes simplex virus.3PubMed. 2021 European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens More recently, proctitis was recognized as a common feature during the mpox outbreak.4PubMed Central. Separating Infectious Proctitis from Inflammatory Bowel Disease-A Common Clinical Conundrum
Gonorrheal proctitis can be surprisingly quiet. Some people have no symptoms at all, while others notice mucus discharge and mild discomfort. Chlamydial proctitis caused by the standard strains tends to be similarly mild. The lymphogranuloma venereum (LGV) strains of chlamydia, however, are a different story. LGV can cause severe rectal pain, bloody mucus, and dramatic-looking inflammation on endoscopy. It mimics Crohn’s disease or ulcerative colitis so convincingly that misdiagnosis is common.5PubMed Central. Lymphogranuloma venereum proctosigmoiditis is a mimicker of inflammatory bowel disease In one case series, all eleven patients with LGV proctitis shared clinical, endoscopic, and tissue-level features with inflammatory bowel disease.6Crohn’s & Colitis 360. Lymphogranuloma venereum proctitis mimicking inflammatory bowel diseases in 11 patients: a 4-year single-center experience
Herpes simplex proctitis has its own distinctive profile. In a study of men with HSV proctitis, every patient reported severe anorectal pain and tenesmus. Roughly half had fever and difficulty urinating, about a quarter experienced numbness or tingling in the lower back and buttocks, and the majority had perianal ulcers. Most telling, about 85 percent of the symptomatic cases turned out to be a first-ever HSV-2 infection rather than a recurrence.7PubMed. Herpes simplex virus proctitis in homosexual men. Clinical, sigmoidoscopic, and histopathological features The combination of intense rectal pain, urinary symptoms, and sacral nerve tingling is a useful clue that the culprit is herpes rather than a bacterial STI.
Why Infectious and Autoimmune Proctitis Look So Similar
One of the genuine headaches in gastroenterology and sexual health clinics is telling infectious proctitis apart from inflammatory bowel disease. Both can produce rectal bleeding, urgency, and discharge. On a scope, both can show redness, swelling, and ulceration. Even biopsy samples can overlap, with inflammatory cell patterns that point in either direction.8PubMed Central. Separating Infectious Proctitis from Inflammatory Bowel Disease-A Common Clinical Conundrum
The consequences of getting this wrong go both ways. If an STI is mistaken for ulcerative colitis, you might end up on immunosuppressive therapy while an infection worsens unchecked. If ulcerative colitis is mistaken for an infection, you spend weeks on antibiotics that do nothing for an autoimmune process. In practice, the diagnosis of LGV proctosigmoiditis in particular often only gets corrected after one or more of the following: IBD therapy fails, sexual history is revisited, a chlamydia antibody test comes back positive, or the patient improves on anti-chlamydia antibiotics.9PubMed Central. Lymphogranuloma venereum proctosigmoiditis is a mimicker of inflammatory bowel disease Even herpes proctitis has been documented masquerading as IBD in young patients.10PubMed Central. Herpes Simplex Proctitis Mimicking Inflammatory Bowel Disease in a Teenaged Male
The takeaway for anyone experiencing rectal symptoms is straightforward: make sure your doctor knows your full sexual history. A lot of diagnostic confusion evaporates once the right tests are ordered, but those tests only get ordered if the clinician knows to look for them.
Ulcerative Proctitis as an IBD Subtype
Ulcerative proctitis is the mildest and most limited form of ulcerative colitis, where inflammation stays confined to the rectum. It is common enough to account for a meaningful fraction of ulcerative colitis diagnoses. Many people with ulcerative proctitis have a relatively manageable course, but the disease does not always stay put.
In a retrospective cohort study, about 20 percent of ulcerative proctitis patients experienced disease progression over a median follow-up of roughly five years. The cumulative risk was around 3 percent at one year, 15 percent at five years, and 23 percent at ten years.11Journal of Crohn’s and Colitis. Incidence and risk factors for disease progression in patients with ulcerative proctitis: a retrospective cohort study Age matters: patients diagnosed before 18 had roughly triple the risk of progression compared to adults. On the encouraging side, achieving steroid-free remission within three months of diagnosis cut the risk of progression roughly in half.12Journal of Crohn’s and Colitis. Incidence and risk factors for disease progression in patients with ulcerative proctitis: a retrospective cohort study
A separate single-center study found a higher progression rate, with 56 percent of patients developing more extensive disease over time. That study also identified high stress levels, more than one flare in the first year, and the use of systemic steroids during mild-to-moderate flares as risk factors for the disease spreading beyond the rectum.13PubMed Central. Natural history and progression risk factors of ulcerative proctitis: a retrospective study from a single tertiary centre in Poland The wide range between studies likely reflects differences in the patient populations studied and how progression was defined, but the message is consistent: early effective treatment that controls inflammation matters for long-term outcomes.
Treating Ulcerative Proctitis
The first-line treatment for ulcerative proctitis is mesalazine (also known as 5-ASA), and the way you deliver it matters a lot. Rectal suppositories consistently outperform oral tablets when the disease is limited to the rectum. In a head-to-head trial, mesalazine suppositories eliminated bloody stools within two weeks in about 75 percent of patients, compared to 26 percent for oral mesalazine at the same total daily dose.14Digestion. Optimized Management of Ulcerative Proctitis: When and How to Use Mesalazine Suppository A separate randomized trial confirmed that suppositories produced significantly greater improvements in symptom scores and histological healing at both two and four weeks compared to tablets.15PubMed. Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis
The logic is simple: a suppository puts the drug directly where the inflammation is, rather than asking it to survive the entire digestive tract and arrive at the rectum in therapeutic concentrations. This is why gastroenterology guidelines typically recommend rectal mesalazine as the starting point for ulcerative proctitis, with oral mesalazine added on if the rectal route alone is not enough.
For people whose disease does not respond to mesalazine, the treatment ladder escalates. In a large referral-center cohort, about 31 percent of ulcerative proctitis patients turned out to be refractory to both rectal and oral 5-ASA combined with corticosteroids. Among those refractory patients, biologic therapies produced clinical response in about 70 percent, while azathioprine alone managed just 11 percent.16United European Gastroenterology Journal. Long-term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort Overall, 87 percent of all ulcerative proctitis patients achieved treatment success over a median follow-up of about six years, even though some required advanced therapies to get there.
Newer Options for Stubborn Cases
Biologics and newer small-molecule drugs are increasingly used for ulcerative proctitis that resists standard treatment, though the evidence base specific to proctitis (as opposed to more extensive ulcerative colitis) remains thin.17PubMed Central. Clinical features and current treatment approach to ulcerative proctitis One multicenter study looked at tofacitinib, a JAK inhibitor taken as a pill, in 35 patients whose ulcerative proctitis had already failed anti-TNF therapy, and nearly 90 percent had been through at least two lines of biologics. After induction, about 43 percent achieved steroid-free remission and 60 percent had a clinical response. At one year, roughly 40 percent remained in remission and about half were still on the drug.18Journal of Crohn’s and Colitis. Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID These are not stellar numbers in an absolute sense, but in a population that had already exhausted multiple treatment lines, sustained remission in four out of ten patients is meaningful.
Radiation Proctitis
Radiation therapy aimed at pelvic cancers, especially prostate, cervical, and rectal cancers, can damage the rectal lining as collateral. This damage comes in two waves. In the short term, radiation injures DNA and disrupts the rapidly dividing cells of the rectal mucosa. In the longer term, the tissue remodeling process involves changes to blood vessels, scarring of the tissue matrix, and chronic low-grade inflammation.19PubMed Central. The dynamic cellular and molecular features during the development of radiation proctitis revealed by transcriptomic profiling in mice
Acute radiation proctitis typically shows up during or shortly after treatment and often resolves on its own within weeks to months. Chronic radiation proctitis is the more troublesome version, sometimes emerging months or years after radiation treatment ends. It can cause persistent rectal bleeding, urgency, and mucus discharge that significantly affects quality of life. Treatment options range from topical therapies and sucralfate enemas to endoscopic procedures like argon plasma coagulation, which cauterizes the abnormal blood vessels responsible for bleeding. Modern radiation techniques that deliver more tightly focused beams have reduced the incidence, but have not eliminated it.
Ischemic Proctitis
When blood flow to the rectum drops severely, the tissue can become ischemic, and unlike ischemia elsewhere in the colon, rectal ischemia is rare because the rectum has a particularly rich blood supply from multiple arterial sources. It takes serious vascular disease or a major hemodynamic event to knock out enough of those supply routes. In one case series, nearly half the cases were tied to aortoiliac occlusive disease, and about 40 percent resulted from dangerously low blood flow states like shock.20PubMed. Ischemic proctitis: case series and literature review
Ischemic proctitis is a medical emergency. Mortality rates range from 20 to 40 percent, and many patients require surgical removal of the rectum as definitive treatment, especially when the tissue damage extends through the full wall thickness.21PubMed Central. Ischemic Proctitis Presenting as Rectal Pain and Bloody Diarrhea with No Apparent Cause This is not a condition people need to lose sleep over as a random occurrence. It overwhelmingly strikes people who already have advanced vascular disease or who are critically ill in hospital settings.
Diversion Proctitis
When a segment of the colon or rectum is surgically bypassed, meaning stool no longer passes through it, that segment can develop its own form of inflammation. This happens because the cells lining the colon depend on short-chain fatty acids produced by gut bacteria fermenting dietary fiber. Without stool flowing through, those fatty acids essentially vanish, and the lining becomes inflamed from nutritional deprivation.22PubMed. Treatment of diversion colitis with short-chain-fatty acid irrigation
The treatment follows directly from the cause. Instilling short-chain fatty acid solutions into the diverted segment clears up both the symptoms and the visible inflammation, typically within four to six weeks.23PubMed. Diversion procto-colitis: response to treatment with short-chain fatty acids Alternatively, reversing the diversion and restoring the normal stool stream resolves the problem entirely. Diversion proctitis is worth knowing about mainly because it can be mistaken for a recurrence of the original disease that prompted surgery, leading to unnecessary worry and overtreatment.
Proctitis in Infants
Babies who develop streaks of blood in their stool during the first weeks or months of life often turn out to have food protein-induced allergic proctocolitis (FPIAP). This is an immune reaction in the lining of the distal colon, most commonly triggered by cow’s milk protein, and it occurs in both breastfed and formula-fed infants.24PubMed Central. To Diet or Not to Diet This Is the Question in Food-Protein-Induced Allergic Proctocolitis (FPIAP)-A Comprehensive Review of Current Recommendations Unlike classic food allergies, FPIAP is not driven by IgE antibodies, so standard allergy blood tests and skin prick tests will not detect it.25PubMed Central. Food protein-induced allergic proctocolitis in infants: Literature review and proposal of a management protocol
Diagnosis is clinical: the bleeding stops when the suspected trigger food is removed from the breastfeeding mother’s diet or when the infant is switched to an extensively hydrolyzed or amino acid-based formula, and it returns if the food is reintroduced. One observational study found that higher maternal dairy consumption during breastfeeding and early exposure to cow’s milk formula within the first week of life were associated with FPIAP.26Asia Pacific Allergy. Maternal dairy intake and infant formula feeding practices in food protein–induced allergic proctocolitis The reassuring part is that FPIAP is transient. Most infants outgrow it and tolerate the triggering food before their first birthday.27PubMed Central. To Diet or Not to Diet This Is the Question in Food-Protein-Induced Allergic Proctocolitis (FPIAP)-A Comprehensive Review of Current Recommendations
Preventing Infectious Proctitis
Condom use during anal intercourse is the most straightforward preventive measure, though adherence in real-world settings is inconsistent. An emerging strategy is doxycycline postexposure prophylaxis, where a dose of the antibiotic is taken after a sexual encounter. Clinical trial data have shown that this approach reduces the incidence of bacterial STIs, including chlamydia and syphilis, in men who have sex with men. The protection against gonorrhea has been less consistent, and there are legitimate concerns that widespread prophylactic antibiotic use could accelerate resistance in gonorrhea and other bacteria.28Medical Clinics of North America. Proctitis: An Approach to the Symptomatic Patient This makes doxycycline prophylaxis a tool that works well in the short term but carries population-level risks that public health officials are still weighing.
Regular STI screening is particularly important for people at higher risk of anorectal infections. Many cases of gonorrheal and chlamydial proctitis produce minimal symptoms, meaning the infection can be transmitted to partners and persist for weeks or months without the person being aware. Screening with rectal swabs (not just urine or genital tests) catches these silent infections before they cause complications or spread further.
Conditions That Mimic Proctitis
Not every case of rectal bleeding and discomfort turns out to be proctitis. Solitary rectal ulcer syndrome, for instance, produces symptoms that look nearly identical, including bleeding, mucus discharge, straining, a feeling of incomplete evacuation, and sometimes abdominal pain. Despite the name, actual ulcers are only found in about 40 percent of patients; the rest have lesions that range from reddened mucosa to polyp-like growths.29PubMed Central. Solitary rectal ulcer syndrome: clinical features, pathophysiology, diagnosis and treatment strategies The condition is linked to disordered defecation and sometimes rectal prolapse, and its management is entirely different from any form of proctitis. Hemorrhoids, anal fissures, and rectal cancer can also mimic some of the symptoms. This is why rectal symptoms generally warrant a proper evaluation rather than self-diagnosis, especially when bleeding persists or is accompanied by changes in bowel habits.